Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-2808.94%EBITDA Margin
VS
Market
Sector
Industry
History
$ 5.78Close
$ 4.28 - $ 12.48 52-Week Range
Ticker Information
Ticker
VIRCompany Name
VIR BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVIR BIOTECHNOLOGY INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VIR - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -533.7M | -2808.94% | $ 19M |
| 3/31/2025 | $ -561.22M | -2690.3% | $ 20.86M |
| 12/31/2024 | $ -503.3M | -678.25% | $ 74.2M |
| 9/30/2024 | $ -517.45M | -658.18% | $ 78.62M |
| 6/30/2024 | $ -468.25M | -593.65% | $ 78.88M |
| 3/31/2024 | $ -524.74M | -659.23% | $ 79.6M |
| 12/31/2023 | $ -601.03M | -697.41% | $ 86.18M |
| 9/30/2023 | $ -633.64M | -533.35% | $ 118.8M |
| 6/30/2023 | $ -251.81M | -51.31% | $ 490.72M |
| 3/31/2023 | $ -291.12M | -65.23% | $ 446.3M |
Key Performance Insights, Last 5 Years
- VIR BIOTECHNOLOGY INC's latest trailing twelve months (TTM) EBITDA % stands at -329.03%.
- Over the past 5 years, VIR BIOTECHNOLOGY INC's average EBITDA % has been -528.06%.
- The median EBITDA % for VIR BIOTECHNOLOGY INC during this period was -354.25%
- VIR BIOTECHNOLOGY INC reached its highest EBITDA % over the past 5 years at 71.08%.
- The lowest EBITDA % recorded by VIR BIOTECHNOLOGY INC in the same timeframe -2808.94%
VIR BIOTECHNOLOGY INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for VIR BIOTECHNOLOGY INC is calculated as follows: EBITDA [ $ -248.79M ] / Revenues [ $ 75.61M ]
(=) EBITDA % [ -329.03% ] VIR - EBITDA Margin, Last 5 years
-2808.94%
Minimum
Jun 30, 2025
71.08%
Maximum
Mar 31, 2022
-528.06%
Average
-354.25%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |